Concepedia

Thomas G. Martin

TG

Statistics

Publications

9

Citations

228

H-Index

9

Active since

1994

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

The Ohio State University

Sanofi (United States)

University of Pittsburgh Medical Center

Thomas G. Martin is an author at University of California, San Francisco specializing in medicine, pharmacology, and hematologic malignancy therapy.

Publications per year

1994–2021

9

Publications

9

Biomarkers of Liver Regeneration Allow Early Prediction of Hepatic Recovery After Acute Necrosis

Kevin D. Horn, Paul M. Wax, Sandra M. Schneider et al. · American Journal of Clinical Pathology · 1999 · 72 citations

, , +17

A Phase Ib Dose Escalation Trial of SAR650984 (Anti-CD-38 mAb) in Combination with Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Thomas G. Martin, Rachid Baz, Don M. Benson et al. · Blood · 2014 · 38 citations

, , +15

Phase Ib Study of Isatuximab and Carfilzomib in Relapse and Refractory Multiple Myeloma

Thomas G. Martin, Gabriel N. Mannis, Ajai Chari et al. · Blood · 2016 · 28 citations

, , +10

Mixed fluoxetine/loxapine overdose and atrial flutter

Raymond J. Roberge, Thomas G. Martin · Annals of Emergency Medicine · 1994 · 20 citations

, , +14

A phase Ib dose escalation trial of SAR650984 (Anti-CD-38 mAb) in combination with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma.

Thomas G. Martin, Karl Hsu, Éric Charpentier et al. · Journal of Clinical Oncology · 2014 · 17 citations

, , +15

1–5 of 9